Clinical Trials Browser

Interventional × Lung Neoplasms × talazoparib × Clear all

NCT04170946 2026-03-05

Talazoparib

Phase 1 Recruiting

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04173507 2024-09-03

Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)

Phase 2 Completed

47 enrolled 17 charts

Lung Neoplasms